Leukocyte telomere length in relation to pancreatic cancer risk: A prospective study

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2447-2454

  Campa, Daniele ^a   Mergarten, Bjöorn ^a   De Vivo, Immaculata ^b,c   Boutron Ruault, Marie Christine ^d,e,f   Racine, Antoine ^d,e,f   Severi, Gianluca ^g   Nieters, Alexandra ^h   Katzke, Verena A ^a   Trichopoulou, Antonia ^i,j   Yiannakouris, Nikos ^i,k   Trichopoulos, Dimitrios ^c,i,j   Boeing, Heiner ^l   Quirós, J Ramón ^m   Duell, Eric J ⁿ   Molina Montes, Esther ^o,p   Huerta, José María ^p,q   Ardanaz, Eva ^p,r   Dorronsoro, Miren ^s   Khaw, Kay Tee ^t   Wareham, Nicholas ^t   Travis, Ruth C ^u   Palli, Domenico ^v   Pala, Valeria ^w   Tumino, Rosario ^x   Naccarati, Alessio ^g   Panico, Salvatore ^y   Vineis, Paolo ^z   Riboli, Elio ^z   Siddiq, Afshan ^z   Bueno de Mesquita, H B ^z,aa,ab   Peeters, Petra H ^ab   Nilsson, Peter M ^ac   Sund, Malin ^ad   Ye, Weimin ^ad,ae   Lund, Eiliv ^af   Jareid, Mie ^af   Weiderpass, Elisabete ^af,ag,ah,ai   Duarte Salles, Talita ^ai   Kong, So Yeon ^ai   Stepien, Magdalena ^ai   Canzian, Federico ^a   Kaaks, Rudolf ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d INSERM   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f IGR   (France)

^g Human Genetics Foundation   (Italy)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ HELLENIC HEALTH FOUNDATION   (Greece)

^j BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^k HAROKOPIO UNIVERSITY   (Greece)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m Environmental Health Unit   (Spain)

ⁿ CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^o ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^p CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^q DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^r INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^s BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^t UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^u UNIVERSITY OF OXFORD   (United Kingdom)

^v CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^w NATIONAL CANCER INSTITUTE   (Italy)

^x CIVILE M P AREZZO HOSPITAL   (Italy)

^y UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^z IMPERIAL COLLEGE LONDON   (United Kingdom)

^aa NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ab UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ac LUND UNIVERSITY   (Sweden)

^ad UMEÅ UNIVERSITY   (Sweden)

^ae KAROLINSKA INSTITUTE   (Sweden)

^af UNIVERSITY OF TROMSØ   (Norway)

^ag CANCER REGISTRY OF NORWAY   (Norway)

^ah Samfundet Folkhäalsan   (Finland)

^ai INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CANCER RISK; CELLULAR PARAMETERS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LEUKOCYTE; LEUKOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PROSPECTIVE STUDY; SMOKING; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; VERY ELDERLY; COHORT ANALYSIS; GENETICS; MIDDLE AGED; PANCREAS TUMOR; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; TELOMERE; TELOMERE SHORTENING;

EID: 84918835252     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0247     Document Type: Article

References (49)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
2. Jemal A, Bray F, CenterMM,Ferlay J, Ward E, FormanD. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
3. Anderson K, Mack T, Silverman D. Cancer of the pancreas. New York: Oxford University Press; 2006.
4. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007;102:2696-707.
5. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-90.
6. Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, et al. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis 2012;45:95-9.
7. Low SK, Kuchiba A, Zembutsu H, Saito A, Takahashi A, Kubo M, et al. Genome-wide association study of pancreatic cancer in Japanese population. PLoS ONE 2010;5:e11824.
8. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg- Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010;42:224-8.
9. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-31.
10. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 2010;70:1015-23.
11. Wu C, Miao X, Huang L, Che X, Jiang G, Yu D, et al. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 2011;44:62-6.
12. Hou L, Zhang X, Gawron AJ, Liu J. Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer Lett 2012;319:130-5.
13. Lynch SM, Major JM, Cawthon R, Weinstein SJ, Virtamo J, Lan Q, et al. A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int J Cancer 2013;133:2672-80.
14. Skinner HG, Gangnon RE, Litzelman K, Johnson RA, Chari ST, Petersen GM, et al. Telomere length and pancreatic cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:2095-100.
15. Boccardi V, Esposito A, Rizzo MR, Marfella R, Barbieri M, Paolisso G. Mediterranean diet, telomere maintenance and health status among elderly. PLoS ONE 2013;8:e62781.
16. Huzen J, Wong LS, van Veldhuisen DJ, Samani NJ, Zwinderman AH, Codd V, et al. Telomere length loss due to smoking and metabolic traits. J Intern Med 2014;275:155-63.
17. Zhang X, Lin S, Funk WE, Hou L. Environmental and occupational exposure to chemicals and telomere length in human studies. Postgrad Med J 2013;89:722-8.
18. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest 2013;123:996-1002.
19. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005;6:611-22.
20. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-8.
21. Chung CC, Chanock SJ. Current status of genome-wide association studies in cancer. Hum Genet 2011;130:59-78.
22. Friedrich U, Griese E, Schwab M, Fritz P, Thon K, Klotz U. Telomere length in different tissues of elderly patients. Mech Ageing Dev 2000;119:89-99.
23. Gardner JP, Kimura M, Chai W, Durrani JF, Tchakmakjian L, Cao X, et al. Telomere dynamics in macaques and humans. J Gerontol A Biol Sci Med Sci 2007;62:367-74.
24. Kimura M, Gazitt Y, Cao X, Zhao X, Lansdorp PM, Aviv A. Synchrony of telomere length among hematopoietic cells. Exp Hematol 2010;38:854-9.
25. Daniali L, Benetos A, Susser E, Kark JD, Labat C, Kimura M, et al. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun 2013;4:1597.
26. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
27. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:e47.
28. Grote VA, Rohrmann S, Nieters A, Dossus L, Tjonneland A, Halkjaer J, et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 2011;54:3037-46.
29. Li R, Hertzmark E, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV9 Macro. 2011 [accessed on 2014 May 20].
30. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005;19:2100-10.
31. de Lange T.How telomeres solve the end-protection problem. Science 2009;326:948-52.
32. Martinez P, Blasco MA. Role of shelterin in cancer and aging. Aging Cell 2010;9:653-66.
33. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000;34:331-58.
34. McGrath M, Wong JYY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007;16:815.
35. Morla M, Busquets X, Pons J, Sauleda J, MacNee W, Agusti A. Telomere shortening in smokers with and without COPD. Eur Respir J 2006;27:525-8.
36. Valdes A, Andrew T, Gardner J, Kimura M, Oelsner E, Cherkas L, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005;366:662-4.
37. Strandberg TE, Strandberg AY, Saijonmaa O, Tilvis RS, Pitkala KH, Fyhrquist F. Association between alcohol consumption in healthy midlife and telomere length in older men. The Helsinki Businessmen Study. Eur J Epidemiol 2012;27:815-22.
38. Lan Q, Cawthon R, Shen M, Weinstein SJ, Virtamo J, Lim U, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res 2009;15:7429-33.
39. Shen M, Cawthon R, Rothman N, Weinstein SJ, Virtamo J, Hosgood HD III, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer 2011;73:133-7.
40. Burke LS, Hyland PL, Pfeiffer RM, Prescott J, Wheeler W, Mirabello L, et al. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS ONE 2013;8:e71121.
41. Lan Q, Cawthon R, Gao Y, Hu W, Hosgood HD III, Barone-Adesi F, et al. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS ONE 2013;8:e59230.
42. Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, et al. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol 2013;37:434-9.
43. Xie H, Wu X, Wang S, Chang D, Pollock RE, Lev D, et al. Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma. Cancer 2013;119:1885-91.
44. Svenson U, Gronlund E, Soderstrom I, Sitaram RT, Ljungberg B, Roos G. Telomere length in relation to immunological parameters in patients with renal cell carcinoma. PLoS ONE 2013;8:e55543.
45. Weischer M, Nordestgaard BG, Cawthon RM, Freiberg JJ Tybjaerg-Hansen A, Bojesen SE. Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst 2013;105:459-68.
46. Jones AM, Beggs AD, Carvajal-Carmona L, Farrington S, Tenesa A, Walker M, et al. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 2012;61:248-54.
47. Robles-Espinoza CD, Harland M, Ramsay AJ, Aoude LG, Quesada V, Ding Z, et al. POT1 loss-of-function variants predispose to familial melanoma. Nat Genet 2014;46:478-81.
48. Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, Cawthon R, et al. Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet 2011;2:19-29.
49. Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 2010;70:3170-6.